Barclays Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX - Get Free Report) had its price target dropped by stock analysts at Barclays from $140.00 to $139.00 in a report released on Thursday,Benzinga reports. The firm presently has an "underweight" rating on the stock. Barclays's price target would suggest a potential downside of 5.26% from the stock's previous close.

Several other equities research analysts also recently issued reports on the company. JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. DA Davidson lowered their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Wells Fargo & Company upped their price target on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Finally, StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, Clorox presently has an average rating of "Hold" and a consensus price target of $159.50.

Remove Ads

Clorox Trading Up 0.3 %

Shares of Clorox stock traded up $0.45 during trading on Thursday, reaching $146.73. 250,396 shares of the company were exchanged, compared to its average volume of 1,275,034. The firm has a market capitalization of $18.08 billion, a price-to-earnings ratio of 40.11, a P/E/G ratio of 2.62 and a beta of 0.45. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37. The business has a 50-day moving average price of $151.34 and a 200-day moving average price of $159.00. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the company earned $2.16 earnings per share. Sell-side analysts anticipate that Clorox will post 7.15 EPS for the current fiscal year.

Institutional Trading of Clorox

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Thrivent Financial for Lutherans raised its stake in shares of Clorox by 2.7% during the 3rd quarter. Thrivent Financial for Lutherans now owns 9,091 shares of the company's stock worth $1,481,000 after purchasing an additional 236 shares in the last quarter. Daiwa Securities Group Inc. raised its position in Clorox by 2.9% during the third quarter. Daiwa Securities Group Inc. now owns 15,240 shares of the company's stock worth $2,483,000 after acquiring an additional 426 shares in the last quarter. FMR LLC raised its position in Clorox by 27.6% during the third quarter. FMR LLC now owns 776,232 shares of the company's stock worth $126,456,000 after acquiring an additional 168,111 shares in the last quarter. Townsquare Capital LLC acquired a new stake in Clorox in the third quarter valued at $363,000. Finally, CreativeOne Wealth LLC bought a new position in shares of Clorox in the 3rd quarter valued at about $213,000. Institutional investors own 78.53% of the company's stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.